We’re proud to announce the official launch of PLURY in the United States — and with it, the debut of our flagship innovation: s4S SOLUTION™, the world’s first clinical prejuvenation product powered by FECS™ (Functionally Enhanced Cell Spheroid) technology.
Developed in partnership with global cell R&D leader S.Biomedics, s4S SOLUTION™ represents a new category in professional skincare — one that focuses on prevention before correction, by supporting the skin’s natural regenerative rhythm and targeting the cellular causes of aging before they appear.
Why s4S SOLUTION™ Matters:
- Backed by biotech innovation and regenerative science
- Delivers cell-secreted growth factors for collagen, elasticity, and skin resilience
- Designed for aesthetic professionals and clinics seeking results beyond hydration or surface-level actives
- Supported by globally patented FECS™ technology, exclusive to PLURY
This marks the beginning of PLURY’s mission to bring science-first skincare and cell therapy solutions to a wider audience. We’re building partnerships with leading clinics and professionals — and redefining what it means to stay young longer.
Welcome to the era of prejuvenation.
For inquiries, training access, or distributor opportunities in the U.S., contact us at: sales@theplury.com